Analytical validation of a multi‐protein, serum‐based assay for disease activity assessments in multiple sclerosis
F Qureshi, W Hu, L Loh, H Patel… - PROTEOMICS …, 2023 - Wiley Online Library
Purpose To characterize and analytically validate the MSDA Test, a multi‐protein, serum‐
based biomarker assay developed using Olink® PEA methodology. Experimental design …
based biomarker assay developed using Olink® PEA methodology. Experimental design …
[PDF][PDF] Analytical validation of a multivariate proteomic serum-based assay for disease activity assessments in multiple sclerosis
F Qureshi, W Hu, L Loh, H Patel… - Medrxiv. Published …, 2022 - academia.edu
Qureshi et al Biomarker Analytical Validation Manuscript MedRxiv 2 glycoprotein; MRI,
magnetic resonance imaging; MS, multiple sclerosis; MSDA, Multiple Sclerosis Disease …
magnetic resonance imaging; MS, multiple sclerosis; MSDA, Multiple Sclerosis Disease …
[PDF][PDF] Matched plasma modification for calculating a disease activity score in a serum-validated multivariate proteomic multiple sclerosis disease activity test
W Hu, F Zhang, L Loh, H Patel… - MULTIPLE …, 2022 - octavebio.com
CONCLUSIONS• A Multiple Sclerosis Disease Activity (MSDA) Test that measures the
concentrations of 18 proteins in serum, and utilizes an algorithm to determine 4 disease …
concentrations of 18 proteins in serum, and utilizes an algorithm to determine 4 disease …